

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.73443984 |
| 2 | leukocyte aggregation (GO:0070486) | 4.69474692 |
| 3 | detection of other organism (GO:0098543) | 4.39928837 |
| 4 | detection of bacterium (GO:0016045) | 4.35623641 |
| 5 | respiratory burst (GO:0045730) | 4.32263688 |
| 6 | immunoglobulin mediated immune response (GO:0016064) | 4.18792986 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17479200 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17479200 |
| 9 | neutrophil activation (GO:0042119) | 4.08756567 |
| 10 | response to peptidoglycan (GO:0032494) | 4.02094278 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.01512494 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.01512494 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.01512494 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.01512494 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.01512494 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.01512494 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.99291960 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97938708 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.97392386 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.93864936 |
| 21 | granulocyte activation (GO:0036230) | 3.92043299 |
| 22 | mast cell activation (GO:0045576) | 3.78437087 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.70317069 |
| 24 | detection of external biotic stimulus (GO:0098581) | 3.65707248 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57566052 |
| 26 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.43747223 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43245817 |
| 28 | response to muramyl dipeptide (GO:0032495) | 3.40772542 |
| 29 | myeloid cell activation involved in immune response (GO:0002275) | 3.40338005 |
| 30 | cellular extravasation (GO:0045123) | 3.38842060 |
| 31 | T cell migration (GO:0072678) | 3.36410208 |
| 32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.33688918 |
| 33 | myeloid dendritic cell activation (GO:0001773) | 3.32045697 |
| 34 | defense response to protozoan (GO:0042832) | 3.31888265 |
| 35 | axon ensheathment in central nervous system (GO:0032291) | 3.30567184 |
| 36 | central nervous system myelination (GO:0022010) | 3.30567184 |
| 37 | amyloid precursor protein catabolic process (GO:0042987) | 3.29294778 |
| 38 | myeloid dendritic cell differentiation (GO:0043011) | 3.29020071 |
| 39 | regulation of T cell tolerance induction (GO:0002664) | 3.28824576 |
| 40 | response to interleukin-15 (GO:0070672) | 3.28080192 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.27801261 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.25513866 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.25398942 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24339329 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.23313110 |
| 46 | germinal center formation (GO:0002467) | 3.23195620 |
| 47 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.23014471 |
| 48 | negative regulation of phagocytosis (GO:0050765) | 3.21558871 |
| 49 | leukocyte degranulation (GO:0043299) | 3.20852528 |
| 50 | detection of biotic stimulus (GO:0009595) | 3.20650854 |
| 51 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20016474 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.19299978 |
| 53 | B cell mediated immunity (GO:0019724) | 3.17003763 |
| 54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.16529998 |
| 55 | positive regulation of B cell differentiation (GO:0045579) | 3.15213190 |
| 56 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.12067531 |
| 57 | response to interferon-beta (GO:0035456) | 3.11823653 |
| 58 | response to protozoan (GO:0001562) | 3.11008702 |
| 59 | regulation of leukocyte degranulation (GO:0043300) | 3.09919715 |
| 60 | positive regulation of interleukin-17 production (GO:0032740) | 3.09403725 |
| 61 | type I interferon signaling pathway (GO:0060337) | 3.08819196 |
| 62 | cellular response to type I interferon (GO:0071357) | 3.08819196 |
| 63 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07402472 |
| 64 | NIK/NF-kappaB signaling (GO:0038061) | 3.07181501 |
| 65 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.06560748 |
| 66 | response to host (GO:0075136) | 3.06560748 |
| 67 | response to host defenses (GO:0052200) | 3.06560748 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.06088442 |
| 69 | regulation of B cell differentiation (GO:0045577) | 3.05868134 |
| 70 | response to type I interferon (GO:0034340) | 3.04485610 |
| 71 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04349812 |
| 72 | cellular response to interleukin-15 (GO:0071350) | 3.04301595 |
| 73 | cellular response to interferon-beta (GO:0035458) | 3.03959097 |
| 74 | positive regulation of interferon-alpha production (GO:0032727) | 3.01320459 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00979495 |
| 76 | neutrophil mediated immunity (GO:0002446) | 3.00356353 |
| 77 | B cell receptor signaling pathway (GO:0050853) | 3.00062814 |
| 78 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98382763 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 2.96035386 |
| 80 | cellular response to zinc ion (GO:0071294) | 2.95795759 |
| 81 | macrophage activation involved in immune response (GO:0002281) | 2.95508019 |
| 82 | tolerance induction (GO:0002507) | 2.94522138 |
| 83 | regulation of interferon-alpha production (GO:0032647) | 2.93871171 |
| 84 | macrophage activation (GO:0042116) | 2.93797394 |
| 85 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.92781740 |
| 86 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.91257207 |
| 87 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.91257207 |
| 88 | microglial cell activation (GO:0001774) | 2.90719997 |
| 89 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.89513643 |
| 90 | positive thymic T cell selection (GO:0045059) | 2.87233303 |
| 91 | negative regulation of innate immune response (GO:0045824) | 2.85795042 |
| 92 | myeloid leukocyte activation (GO:0002274) | 2.85730690 |
| 93 | regulation of antigen processing and presentation (GO:0002577) | 2.84567979 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83748928 |
| 95 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83658478 |
| 96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.83128941 |
| 97 | leukocyte cell-cell adhesion (GO:0007159) | 2.82400104 |
| 98 | response to fungus (GO:0009620) | 2.81669792 |
| 99 | negative regulation of interleukin-6 production (GO:0032715) | 2.78956143 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.78956134 |
| 101 | dendritic cell differentiation (GO:0097028) | 2.76573842 |
| 102 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.76341800 |
| 103 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75462924 |
| 104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75454287 |
| 105 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.75233984 |
| 106 | regulation of mast cell degranulation (GO:0043304) | 2.75230190 |
| 107 | positive regulation of interleukin-10 production (GO:0032733) | 2.75028994 |
| 108 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.73902807 |
| 109 | regulation of growth of symbiont in host (GO:0044126) | 2.73902807 |
| 110 | negative regulation of growth of symbiont in host (GO:0044130) | 2.73902807 |
| 111 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.73902807 |
| 112 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.71490062 |
| 113 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.70927016 |
| 114 | positive regulation of mast cell degranulation (GO:0043306) | 2.70927016 |
| 115 | leukocyte mediated cytotoxicity (GO:0001909) | 2.70785899 |
| 116 | pinocytosis (GO:0006907) | 2.70502447 |
| 117 | regulation of mast cell activation (GO:0033003) | 2.70454684 |
| 118 | T-helper 1 type immune response (GO:0042088) | 2.70237765 |
| 119 | amyloid precursor protein metabolic process (GO:0042982) | 2.70156021 |
| 120 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.69677645 |
| 121 | regulation of interleukin-17 production (GO:0032660) | 2.66702278 |
| 122 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.64802771 |
| 123 | regulation of hypersensitivity (GO:0002883) | 2.64642851 |
| 124 | response to host immune response (GO:0052572) | 2.64216717 |
| 125 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.64216717 |
| 126 | negative regulation of interleukin-12 production (GO:0032695) | 2.63356933 |
| 127 | regulation of gamma-delta T cell activation (GO:0046643) | 2.63206352 |
| 128 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.63132540 |
| 129 | negative thymic T cell selection (GO:0045060) | 2.60356975 |
| 130 | regulation of lymphocyte migration (GO:2000401) | 2.60211043 |
| 131 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.58050275 |
| 132 | regulation of chemokine biosynthetic process (GO:0045073) | 2.56352218 |
| 133 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.55403005 |
| 134 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.54913678 |
| 135 | negative regulation of cell killing (GO:0031342) | 2.54913678 |
| 136 | negative T cell selection (GO:0043383) | 2.53374591 |
| 137 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.51981726 |
| 138 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.51901355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.14927476 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89560398 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.28638523 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.86384614 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72260680 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.70918949 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.35199867 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.28273926 |
| 9 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.19317346 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.11218203 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06116370 |
| 12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.05998880 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.96080022 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.80588311 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68824100 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.61185774 |
| 17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56811943 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.56216369 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.54153826 |
| 20 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52471520 |
| 21 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.35762963 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.35274639 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.30788436 |
| 24 | * MYB_26560356_Chip-Seq_TH2_Human | 2.19963976 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18102615 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 2.08244484 |
| 27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07662154 |
| 28 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06644348 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03829367 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02510712 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00804959 |
| 32 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.99153376 |
| 33 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91602764 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.91426661 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.89709655 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87796736 |
| 37 | * MYB_26560356_Chip-Seq_TH1_Human | 1.76763562 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76318958 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73392510 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.72736095 |
| 41 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.68077832 |
| 42 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.66340105 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64780202 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64093917 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58298030 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57128358 |
| 47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.55367199 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54100053 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.52212557 |
| 50 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51624328 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51404791 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49353093 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47914530 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46480457 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45340703 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45321955 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.44007879 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39032467 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36469153 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35906448 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35111906 |
| 62 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33658880 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31133084 |
| 64 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28818819 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25362680 |
| 66 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22470765 |
| 67 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20556743 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18774012 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18677150 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18222270 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16993591 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16928044 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14812070 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14568700 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13824196 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12828630 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12524971 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11964836 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11520084 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10269044 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08769132 |
| 82 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.06919833 |
| 83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05520569 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05501458 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03173751 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02499100 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02364392 |
| 88 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99066867 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97479824 |
| 90 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97365502 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97320978 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96277229 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94324443 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93737627 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93056527 |
| 96 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92777738 |
| 97 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92673182 |
| 98 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91679275 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91307611 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90918083 |
| 101 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90840655 |
| 102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89991881 |
| 103 | P68_20966046_ChIP-Seq_HELA_Human | 0.89970688 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89901918 |
| 105 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88964203 |
| 106 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.88746303 |
| 107 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88241261 |
| 108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87390891 |
| 109 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.86471041 |
| 110 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.84996843 |
| 111 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.83996240 |
| 112 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.83872908 |
| 113 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82929217 |
| 114 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.79950021 |
| 115 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.79285739 |
| 116 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.78563772 |
| 117 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.78370005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.05486786 |
| 2 | MP0009785_altered_susceptibility_to | 3.48737723 |
| 3 | MP0003436_decreased_susceptibility_to | 3.38099309 |
| 4 | MP0000685_abnormal_immune_system | 3.18751290 |
| 5 | MP0005671_abnormal_response_to | 3.16721562 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.15415443 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.08147040 |
| 8 | MP0002419_abnormal_innate_immunity | 3.02847691 |
| 9 | MP0006082_CNS_inflammation | 2.98774152 |
| 10 | MP0005025_abnormal_response_to | 2.92653783 |
| 11 | MP0003303_peritoneal_inflammation | 2.88632433 |
| 12 | MP0001790_abnormal_immune_system | 2.87959750 |
| 13 | MP0005387_immune_system_phenotype | 2.87959750 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.78618069 |
| 15 | * MP0001800_abnormal_humoral_immune | 2.68515271 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.64104071 |
| 17 | MP0003724_increased_susceptibility_to | 2.63748627 |
| 18 | * MP0002723_abnormal_immune_serum | 2.61098495 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.49235472 |
| 20 | * MP0001819_abnormal_immune_cell | 2.47857358 |
| 21 | MP0002405_respiratory_system_inflammati | 2.23084010 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.21548889 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.20408917 |
| 24 | MP0000920_abnormal_myelination | 2.15209625 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.13433692 |
| 26 | MP0009840_abnormal_foam_cell | 2.01290964 |
| 27 | * MP0002398_abnormal_bone_marrow | 1.98637113 |
| 28 | * MP0000716_abnormal_immune_system | 1.98328724 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.94275408 |
| 30 | MP0004510_myositis | 1.87610131 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.83086954 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.82379013 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.79543068 |
| 34 | MP0001853_heart_inflammation | 1.78326992 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.78068263 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.73038621 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.72149250 |
| 38 | MP0004947_skin_inflammation | 1.68291793 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.65978688 |
| 40 | * MP0002429_abnormal_blood_cell | 1.65313666 |
| 41 | MP0002722_abnormal_immune_system | 1.63775069 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.61392870 |
| 43 | MP0000343_altered_response_to | 1.58877282 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.57555849 |
| 45 | MP0002933_joint_inflammation | 1.55829927 |
| 46 | MP0005310_abnormal_salivary_gland | 1.54014904 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.53932953 |
| 48 | MP0002006_tumorigenesis | 1.49398712 |
| 49 | MP0008469_abnormal_protein_level | 1.48839574 |
| 50 | MP0001873_stomach_inflammation | 1.45101347 |
| 51 | MP0001851_eye_inflammation | 1.43332688 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.39776013 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.39776013 |
| 54 | MP0003075_altered_response_to | 1.34035690 |
| 55 | MP0009278_abnormal_bone_marrow | 1.32701209 |
| 56 | MP0003690_abnormal_glial_cell | 1.27473855 |
| 57 | MP0003448_altered_tumor_morphology | 1.26995695 |
| 58 | MP0009764_decreased_sensitivity_to | 1.26572739 |
| 59 | MP0000858_altered_metastatic_potential | 1.24516875 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.22830463 |
| 61 | MP0003866_abnormal_defecation | 1.16220512 |
| 62 | MP0000490_abnormal_crypts_of | 1.14701092 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.13334489 |
| 64 | MP0003186_abnormal_redox_activity | 1.11437738 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.10845380 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.07197976 |
| 67 | MP0000604_amyloidosis | 1.06438109 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.04979524 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.03630523 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.01756060 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.01399049 |
| 72 | MP0008004_abnormal_stomach_pH | 1.01358426 |
| 73 | MP0004381_abnormal_hair_follicle | 0.98584952 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.94945613 |
| 75 | MP0005451_abnormal_body_composition | 0.93340857 |
| 76 | MP0006054_spinal_hemorrhage | 0.88948404 |
| 77 | MP0004883_abnormal_blood_vessel | 0.88688668 |
| 78 | MP0005166_decreased_susceptibility_to | 0.86426958 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.86258672 |
| 80 | MP0008260_abnormal_autophagy | 0.85590104 |
| 81 | MP0009763_increased_sensitivity_to | 0.84168801 |
| 82 | MP0005390_skeleton_phenotype | 0.83249499 |
| 83 | MP0002132_abnormal_respiratory_system | 0.79467290 |
| 84 | MP0001663_abnormal_digestive_system | 0.78339051 |
| 85 | MP0005164_abnormal_response_to | 0.78016170 |
| 86 | MP0000249_abnormal_blood_vessel | 0.77646324 |
| 87 | MP0003950_abnormal_plasma_membrane | 0.76468199 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.74289606 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.71653457 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.71556286 |
| 91 | MP0002254_reproductive_system_inflammat | 0.68454500 |
| 92 | MP0005023_abnormal_wound_healing | 0.68350931 |
| 93 | MP0008874_decreased_physiological_sensi | 0.66712884 |
| 94 | MP0005409_darkened_coat_color | 0.66058256 |
| 95 | MP0003828_pulmonary_edema | 0.64190473 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.64076505 |
| 97 | MP0008873_increased_physiological_sensi | 0.63705936 |
| 98 | MP0003795_abnormal_bone_structure | 0.63346509 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.60328216 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.58448274 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.57082843 |
| 102 | MP0001542_abnormal_bone_strength | 0.56658060 |
| 103 | MP0008438_abnormal_cutaneous_collagen | 0.56632213 |
| 104 | MP0000609_abnormal_liver_physiology | 0.56329311 |
| 105 | MP0003045_fibrosis | 0.55923360 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.55740277 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.55012784 |
| 108 | MP0008057_abnormal_DNA_replication | 0.54881967 |
| 109 | MP0001958_emphysema | 0.53737241 |
| 110 | MP0005165_increased_susceptibility_to | 0.53295167 |
| 111 | MP0001243_abnormal_dermal_layer | 0.52949374 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52825530 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.52682637 |
| 114 | MP0003091_abnormal_cell_migration | 0.51260865 |
| 115 | MP0003634_abnormal_glial_cell | 0.49863703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.42329913 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.70142017 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.66771245 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.44394940 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.53218410 |
| 6 | Stomatitis (HP:0010280) | 4.36681575 |
| 7 | Chronic otitis media (HP:0000389) | 4.36526916 |
| 8 | Myositis (HP:0100614) | 4.25105680 |
| 9 | Recurrent skin infections (HP:0001581) | 4.10940533 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.06651225 |
| 11 | Obstructive lung disease (HP:0006536) | 4.06651225 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.79987197 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.72377727 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.72212209 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.68674281 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.67906624 |
| 17 | Petechiae (HP:0000967) | 3.64774137 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.55189316 |
| 19 | Recurrent viral infections (HP:0004429) | 3.40706699 |
| 20 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.40496349 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.35514549 |
| 22 | Cellulitis (HP:0100658) | 3.33757552 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 3.28695791 |
| 24 | Encephalitis (HP:0002383) | 3.26194022 |
| 25 | Hepatosplenomegaly (HP:0001433) | 3.23767470 |
| 26 | Vasculitis (HP:0002633) | 3.18943735 |
| 27 | Axonal loss (HP:0003447) | 3.18586949 |
| 28 | Orchitis (HP:0100796) | 3.18170831 |
| 29 | Meningitis (HP:0001287) | 3.13195508 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 3.09580276 |
| 31 | IgM deficiency (HP:0002850) | 3.09043218 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 3.08174126 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.07898929 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.90591617 |
| 35 | Optic neuritis (HP:0100653) | 2.88589601 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.88589601 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86594672 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86594672 |
| 39 | Abnormality of T cell number (HP:0011839) | 2.86587771 |
| 40 | Gingivitis (HP:0000230) | 2.86508625 |
| 41 | Keratoconjunctivitis (HP:0001096) | 2.82229645 |
| 42 | Pustule (HP:0200039) | 2.81806324 |
| 43 | Leukocytosis (HP:0001974) | 2.81146357 |
| 44 | Urticaria (HP:0001025) | 2.75670837 |
| 45 | Chest pain (HP:0100749) | 2.74790094 |
| 46 | Thrombocytosis (HP:0001894) | 2.74212393 |
| 47 | T lymphocytopenia (HP:0005403) | 2.71951423 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.69798573 |
| 49 | Episodic fever (HP:0001954) | 2.60919751 |
| 50 | Recurrent bronchitis (HP:0002837) | 2.60732867 |
| 51 | Abnormality of T cells (HP:0002843) | 2.59672508 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.58782519 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.58663270 |
| 54 | Amyloidosis (HP:0011034) | 2.58027284 |
| 55 | Eosinophilia (HP:0001880) | 2.57464851 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.51776219 |
| 57 | Purpura (HP:0000979) | 2.48653613 |
| 58 | Hypochromic microcytic anemia (HP:0004840) | 2.47940258 |
| 59 | Parakeratosis (HP:0001036) | 2.46243110 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.46215619 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.46215619 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.46215619 |
| 63 | Hypochromic anemia (HP:0001931) | 2.46211493 |
| 64 | Anorexia (HP:0002039) | 2.44811174 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.43996022 |
| 66 | Severe combined immunodeficiency (HP:0004430) | 2.43875357 |
| 67 | Recurrent pneumonia (HP:0006532) | 2.42545780 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.41556595 |
| 69 | Thyroiditis (HP:0100646) | 2.40113311 |
| 70 | Lymphopenia (HP:0001888) | 2.39540427 |
| 71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38901716 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 2.38140503 |
| 73 | Loss of speech (HP:0002371) | 2.37791840 |
| 74 | Nasal polyposis (HP:0100582) | 2.37512756 |
| 75 | Abnormality of eosinophils (HP:0001879) | 2.37434163 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.37329388 |
| 77 | Arterial thrombosis (HP:0004420) | 2.34495295 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 2.34415063 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.34321715 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.32544166 |
| 81 | Neurofibrillary tangles (HP:0002185) | 2.31799024 |
| 82 | Pulmonary embolism (HP:0002204) | 2.31065756 |
| 83 | Gingival bleeding (HP:0000225) | 2.31019618 |
| 84 | Epistaxis (HP:0000421) | 2.28342857 |
| 85 | Granulocytopenia (HP:0001913) | 2.27631237 |
| 86 | Combined immunodeficiency (HP:0005387) | 2.26514011 |
| 87 | Basal ganglia calcification (HP:0002135) | 2.25048474 |
| 88 | Disinhibition (HP:0000734) | 2.24484323 |
| 89 | Agammaglobulinemia (HP:0004432) | 2.24195909 |
| 90 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.22543425 |
| 91 | Gangrene (HP:0100758) | 2.20940884 |
| 92 | Hemoptysis (HP:0002105) | 2.20592809 |
| 93 | Colitis (HP:0002583) | 2.20060396 |
| 94 | Abnormality of the pleura (HP:0002103) | 2.19779500 |
| 95 | Autoimmune hemolytic anemia (HP:0001890) | 2.18777023 |
| 96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18362471 |
| 97 | Mucopolysacchariduria (HP:0008155) | 2.18362471 |
| 98 | Increased IgM level (HP:0003496) | 2.18234381 |
| 99 | Increased serum ferritin (HP:0003281) | 2.18189327 |
| 100 | Osteomyelitis (HP:0002754) | 2.18043102 |
| 101 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17579514 |
| 102 | Progressive neurologic deterioration (HP:0002344) | 2.16319806 |
| 103 | Hypertensive crisis (HP:0100735) | 2.12916053 |
| 104 | Sepsis (HP:0100806) | 2.11789048 |
| 105 | Microcytic anemia (HP:0001935) | 2.11518816 |
| 106 | Poor head control (HP:0002421) | 2.11310186 |
| 107 | Increased IgE level (HP:0003212) | 2.10321160 |
| 108 | Abnormality of the prostate (HP:0008775) | 2.10241542 |
| 109 | B lymphocytopenia (HP:0010976) | 2.10128892 |
| 110 | Abnormality of B cell number (HP:0010975) | 2.10128892 |
| 111 | Premature loss of primary teeth (HP:0006323) | 2.05495551 |
| 112 | Skin ulcer (HP:0200042) | 2.05187263 |
| 113 | Glomerulonephritis (HP:0000099) | 2.05082441 |
| 114 | IgG deficiency (HP:0004315) | 2.04358614 |
| 115 | Periodontitis (HP:0000704) | 2.03443998 |
| 116 | Glomerulopathy (HP:0100820) | 2.02095073 |
| 117 | Polycythemia (HP:0001901) | 2.00236342 |
| 118 | Prolonged bleeding time (HP:0003010) | 1.99829051 |
| 119 | Polyneuropathy (HP:0001271) | 1.98428324 |
| 120 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98117975 |
| 121 | Restrictive lung disease (HP:0002091) | 1.97729434 |
| 122 | Chronic diarrhea (HP:0002028) | 1.96802866 |
| 123 | Arthralgia (HP:0002829) | 1.96508207 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.95727478 |
| 125 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94090362 |
| 126 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94090362 |
| 127 | Skin rash (HP:0000988) | 1.92641787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.16820093 |
| 2 | BLK | 3.30053196 |
| 3 | IRAK4 | 2.98853677 |
| 4 | EPHB1 | 2.98638448 |
| 5 | TBK1 | 2.80924399 |
| 6 | MAP3K14 | 2.61863987 |
| 7 | TXK | 2.55930476 |
| 8 | TYK2 | 2.42528755 |
| 9 | KIT | 2.24331764 |
| 10 | IKBKE | 2.22712131 |
| 11 | CLK1 | 2.20404639 |
| 12 | TESK2 | 2.16860261 |
| 13 | BTK | 2.09200715 |
| 14 | PIM2 | 2.01597933 |
| 15 | ZAP70 | 1.99548443 |
| 16 | MAP3K3 | 1.98172936 |
| 17 | TAOK1 | 1.93269691 |
| 18 | TAOK2 | 1.92045779 |
| 19 | TEC | 1.91781051 |
| 20 | STK10 | 1.89893580 |
| 21 | IKBKB | 1.85369170 |
| 22 | CSF1R | 1.82773324 |
| 23 | ERN1 | 1.82700558 |
| 24 | TGFBR2 | 1.73752279 |
| 25 | JAK3 | 1.72865497 |
| 26 | KDR | 1.69326288 |
| 27 | ITK | 1.67977302 |
| 28 | CSK | 1.67258048 |
| 29 | RIPK4 | 1.60861864 |
| 30 | SIK3 | 1.60159747 |
| 31 | NME2 | 1.58738133 |
| 32 | SYK | 1.53037712 |
| 33 | IRAK3 | 1.48163514 |
| 34 | LCK | 1.36765181 |
| 35 | HCK | 1.34278762 |
| 36 | MST4 | 1.32040284 |
| 37 | FES | 1.26223956 |
| 38 | MAPKAPK5 | 1.25304408 |
| 39 | LYN | 1.23119604 |
| 40 | JAK1 | 1.20959414 |
| 41 | PBK | 1.20296999 |
| 42 | LRRK2 | 1.17345704 |
| 43 | BMPR2 | 1.15869016 |
| 44 | MAP2K3 | 1.14893809 |
| 45 | STK39 | 1.10260436 |
| 46 | TRPM7 | 1.09261214 |
| 47 | FGR | 1.04177691 |
| 48 | CDK19 | 0.99669216 |
| 49 | LIMK1 | 0.98804630 |
| 50 | PIM1 | 0.93675532 |
| 51 | SMG1 | 0.93440126 |
| 52 | GRK6 | 0.92405889 |
| 53 | MAP3K13 | 0.88510750 |
| 54 | PKN1 | 0.87670344 |
| 55 | TRIB3 | 0.85519911 |
| 56 | RPS6KA4 | 0.84243878 |
| 57 | MAP3K11 | 0.84121089 |
| 58 | SIK2 | 0.80946082 |
| 59 | TESK1 | 0.80198674 |
| 60 | CDC42BPA | 0.77135012 |
| 61 | KSR2 | 0.74493206 |
| 62 | TAOK3 | 0.73193277 |
| 63 | PRKD2 | 0.72921121 |
| 64 | NLK | 0.71839001 |
| 65 | PRKCQ | 0.70966635 |
| 66 | JAK2 | 0.70076796 |
| 67 | SIK1 | 0.69892921 |
| 68 | EIF2AK3 | 0.69289900 |
| 69 | MAP3K10 | 0.68518765 |
| 70 | STK4 | 0.66831586 |
| 71 | FGFR4 | 0.66640872 |
| 72 | IRAK1 | 0.65882142 |
| 73 | CHUK | 0.64950424 |
| 74 | MAPKAPK2 | 0.64890360 |
| 75 | OXSR1 | 0.63906840 |
| 76 | GRK7 | 0.63374635 |
| 77 | PDPK1 | 0.62521559 |
| 78 | MATK | 0.60945144 |
| 79 | MARK2 | 0.60073221 |
| 80 | PTK6 | 0.59159630 |
| 81 | MAP3K5 | 0.58192424 |
| 82 | MAPK12 | 0.55867090 |
| 83 | ARAF | 0.55764544 |
| 84 | BMX | 0.55732516 |
| 85 | PRKCD | 0.55642856 |
| 86 | IRAK2 | 0.55432323 |
| 87 | RPS6KA5 | 0.55118707 |
| 88 | ABL1 | 0.49625837 |
| 89 | MOS | 0.48470475 |
| 90 | ABL2 | 0.47350042 |
| 91 | MAPK4 | 0.46784253 |
| 92 | EIF2AK2 | 0.46242432 |
| 93 | MAP2K6 | 0.45791558 |
| 94 | MAP3K8 | 0.45524019 |
| 95 | MAP3K6 | 0.44265972 |
| 96 | PAK4 | 0.44250651 |
| 97 | RPS6KC1 | 0.43942828 |
| 98 | RPS6KL1 | 0.43942828 |
| 99 | PRKG2 | 0.43008652 |
| 100 | FYN | 0.41262945 |
| 101 | YES1 | 0.40919186 |
| 102 | MARK3 | 0.40299237 |
| 103 | MAPK7 | 0.39346601 |
| 104 | CDK4 | 0.39033423 |
| 105 | RPS6KA6 | 0.37628226 |
| 106 | MET | 0.37586461 |
| 107 | ILK | 0.36239532 |
| 108 | FLT3 | 0.35973505 |
| 109 | EGFR | 0.35442663 |
| 110 | SCYL2 | 0.35412133 |
| 111 | PRPF4B | 0.34589147 |
| 112 | PIK3CG | 0.34529312 |
| 113 | ROCK2 | 0.34208280 |
| 114 | BUB1 | 0.34144584 |
| 115 | MAPK11 | 0.33898081 |
| 116 | PAK1 | 0.33772294 |
| 117 | NEK9 | 0.33167712 |
| 118 | ALK | 0.32435768 |
| 119 | CSNK1G3 | 0.32250666 |
| 120 | TNK2 | 0.31805183 |
| 121 | RAF1 | 0.29194634 |
| 122 | CSNK1A1L | 0.29027517 |
| 123 | STK16 | 0.28618718 |
| 124 | HIPK2 | 0.28499936 |
| 125 | DAPK2 | 0.28386014 |
| 126 | MAP3K1 | 0.27961042 |
| 127 | PTK2B | 0.27712670 |
| 128 | ADRBK2 | 0.27502742 |
| 129 | MAP2K2 | 0.27334231 |
| 130 | DAPK3 | 0.25145690 |
| 131 | PDK1 | 0.24250028 |
| 132 | TNIK | 0.23400259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.05772178 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.65096510 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.40796778 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.40545957 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31279616 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.30616631 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24855843 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.21651543 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19741989 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.14992360 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07276821 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.03732441 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.03369345 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.98369883 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.95769153 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94348034 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.91747545 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86774602 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.84854770 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.82153236 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81317696 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74805934 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74411972 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72744218 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.69231052 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.65450761 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.58648782 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43390805 |
| 29 | * Shigellosis_Homo sapiens_hsa05131 | 1.42225424 |
| 30 | DNA replication_Homo sapiens_hsa03030 | 1.40247242 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39978301 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38742025 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37604475 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36262275 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36248519 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35174752 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35057077 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33898614 |
| 39 | * Salmonella infection_Homo sapiens_hsa05132 | 1.31254543 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30611368 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.29930973 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29192949 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.28911419 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.25121158 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.22904076 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.20111957 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.09609264 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09265512 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07138621 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02755064 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.99857590 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96146833 |
| 53 | Proteasome_Homo sapiens_hsa03050 | 0.95968648 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95394706 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94772700 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94100690 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89984716 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85699989 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.82740034 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.82031919 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.80234525 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79853781 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79549825 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79169199 |
| 65 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77385089 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76643478 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76457365 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.74579034 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74203610 |
| 70 | Mismatch repair_Homo sapiens_hsa03430 | 0.72506353 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70626816 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69131749 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68126585 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.65629778 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63917020 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60494731 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.59524525 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59519227 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56665485 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54469779 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54139288 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53756644 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53096921 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52564598 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.51591994 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.49310576 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48271037 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.45338196 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42930274 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42747110 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.41438582 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40328753 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39505893 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38815069 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38733200 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37987035 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37811051 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35208513 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35132830 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34707223 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34587444 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34576045 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33343189 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33211149 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30057425 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29145649 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29134134 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28432480 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27571308 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.26987204 |
| 111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.26916386 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25831869 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25485827 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25022659 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24507737 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24081303 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.22523764 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21968192 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21147683 |
| 120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.17968217 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17584982 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16293416 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15912959 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.15443055 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15133361 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14995941 |

